China's demand for blood treatment disease drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers in China are profiled. Research Beam Model: Research Beam Product ID: 577 4000 USD New
Blood Disease Treatment Drugs Markets in China
 
 

Blood Disease Treatment Drugs Markets in China

  • Category : Pharmaceuticals
  • Published On : May   2013
  • Pages : 255
  • Publisher : Asia Market Info And Dev Co.
 
 
 
China's demand for blood treatment disease drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers in China are profiled.

TABLE OF CONTENTS



I. INTRODUCTION



Report Scope and Methodology

Executive Summary



II. BUSINESS ENVIRONMENT



Economic Outlook

Key Economic Indicators

Industrial Output

Population and Labor

Foreign Investment

Foreign Trade

Financial and Tax Regulations

Banking System and Regulations

Foreign Exchange

Taxes, Tariff and Custom Duties



III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS



Blood Disease Drugs Industry Structure

Market Size

Market Growth Drivers

Blood Disease Drugs Sales Volume

Major Producer Facility Locations and Sales Volume

Market Share of Key Producers

Labor Cost

Potential Entrants

Major Distributors

Major Foreign Investment

Technology Development

IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND

Overview

Demand of Blood Disease Drugs by Region

Blood Disease Drugs Sales Volume

Anemia Treatment Drugs

Mecobalamin

Cobamamide

Ferrous Succinate

Leucogen

Neutropenia and Agranulocytosis Treatment Drugs

VitamineB4

Batilol

Inosine

Deoxyribonucleotide

Adrenocortical Hormone

Granulocyte Colony-Stimulating Factor(G-CSF)

Leukemia Treatment Drugs Sales Volume

Interferon

Imatinib

Rituximab

Pirarubicin

Hydroxycampothecin

Other Blood Disease Drugs Sales Volume

Blood Disease Drugs Imports

Anemia Treatment Drugs

Mecobalamin

Cobamamide

Ferrous Succinate

Leucogen

Neutropenia and Agranulocytosis Treatment Drugs Imports

VitamineB4

Batilol

Inosine

Deoxyribonucleotide

Adrenocortical Hormone

Granulocyte Colony-Stimulating Factor(G-CSF)

Leukemia Treatment Drugs Imports

Interferon

Imatinib

Rituximab

Pirarubicin

Hydroxycampothecin

Other Blood Disease Drugs Imports

Pricing Trends



V. BLOOD DISEASE DRUGS MARKET OUTLOOK



Blood Disease Drugs Market Outlook Overview

Government Regulation

Health Care Insurance Industry Overview

Consumer Spending Trends

Northeast

North

Southeast

Central

Southwest

Northwest

Demographic Trends

Health Care Industry Trends

Hospitals and Hospital Beds



VI. MARKETING STRATEGIES



China Market Entry Overview



China’s Distribution System

Special Rubber Distribution Channels

Transportation and Freight Infrastructure

Communications



China’s Market Entry



Export to China

Indirect export

Direct Export

License and Contract Manufacture

Assembling in China

Contract Manufacturing

Trade Permit

Investment

Equity Joint Venture

Contractual Joint Venture

Wholly Foreign-Owned Enterprise



VII. BLOOD DISEASE DRUGS PRODUCER DIRECTORY



Blood Disease Drugs Producer Profiles

Distributors and Trading Companies

Research Institutions and Associations



LIST OF TABLES



I. INTRODUCTION



Economic Outlook Summary



II. BUSINESS ENVIRONMENT



Key Economic Indicators

Industrial Output

Population and Labor Force Trends

Foreign Investment and Loans

Foreign Trade



III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS



Anemia Treatment Drugs Sales Volume by Drugs Classification

Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification

Leukemia Treatment Drugs Sales Volume by Drugs Classification

Blood Disease Drugs Sales Volume

Major Producer Facility Location

Major Blood Disease Drugs Producer Sales Volume

Market Share of Key Producers

Major Foreign Investment in China



IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND



Total Blood Disease Drugs Sales Volume

Blood Disease Drugs Major Producer and Their Market Share

Anemia Major Producer and Their Market Share

Anemia Treatment Drugs Sales Volume by Drugs Classification

Anemia Treatment Drugs Major Producer and Their Market Share

Mecobalamin Major Producer and Their Market Share

Cobamamide Major Producer and Their Market Share

Ferrous Succinate Major Producer and Their Market Share

Leucogen Major Producer and Their Market Share

Neutropenia and Agranulocytosis Treatment Drugs Major Producer and Their Market Share

Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification

VitamineB4 Major Producer and Their Market Share

Batilol Major Producer and Their Market Share

Inosine Major Producer and Their Market Share

Deoxyribonucleotide Major Producer and Their Market Share

Adrenocortical Hormone Major Producer and Their Market Share

Granulocyte Colony-Stimulating Factor(G-CSF) Major Producer and Their Market Share

Leukemia Treatment Drugs Major Producer and Their Market Share

Leukemia Treatment Drugs Sales Volume by Drugs Classification

Interferon Major Producers and Their Market Share

Imatinib Mesylate Major Producer and Their Market Share

Rituximab Major Producer and Their Market Share

Pirarubicin Major Producer and Their Market Share

Hydroxycampothecin Major Producer and Their Market Share

Blood Disease Drugs Import

Anemia Treatment Drugs Import Volume by Drugs Classification

Neutropenia and Agranulocytosis Treatment Drugs Import Volume by Drugs Classification

Leukemia Treatment Drugs Import Volume by Drugs Classification



V. BLOOD DISEASE DRUGS MARKET OUTLOOK



Consumer Spending Trend

The Structure of Per Capita Expenditure in the Northeast of China

The Structure of Per Capita Expenditure in the North of China

The Structure of Per Capita Expenditure in the Southeast of China

The Structure of Per Capita Expenditure in the Central of China

The Structure of Per Capita Expenditure in the Southwest of China

The Structure of Per Capita Expenditure in the Northwest of China

Demographic Trends

Health Care Industry Trends

Hospitals and Hospital Beds



LIST OF CHARTS



I. NTRODUCTION



Blood Disease Drugs Sales Volume



II. BUSINESS ENVIRONMENT



China’s GDP and Industrial Output

Industrial Output by Ownership

China’s Imports and Exports



III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS



Anemia Treatment Drugs Sales Volume by Drugs Classification

Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification

Leukemia Treatment Drugs Sales Volume by Drugs Classification

Blood Disease Drugs Sales Volume



IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND



Blood Disease Drugs Sales Volume

Worldwide Blood Disease Drugs Demand by region

Anemia Major Producer and Their Market Share

Anemia Treatment Drugs Sales Volume by Drugs Classification

Mecobalamin Sales Volume and Market Share

Cobamamide Sales Volume and Market Share

Ferrous Succinate Sales Volume and Market Share

Leucogen Sales Volume and Market Share

Neutropenia and Agranulocytosis Treatment Drugs Sales Volume and Market Share

Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification

VitamineB4 Sales Volume and Market Share

Batilol Sales Volume and Market Share

Inosine Sales Volume and Market Share

Deoxyribonucleotide Sales Volume and Market Share

Adrenocortical Hormone Sales Volume and Market Share

Granulocyte Colony-Stimulating Factor(G-CSF) Sales Volume and Market Share

Leukemia Treatment Drugs Sales Volume and Market Share

Leukemia Treatment Drugs Sales Volume by Drugs Classification

Interferon Sales Volume and Market Share

Imatinib Mesylate Sales Volume and Market Share

Rituximab Sales Volume and Market Share

Pirarubicin Sales Volume and Market Share

Hydroxycampothecin Sales Volume and Market Share

Other Blood Disease Drugs Sales volume and Market Share

Blood Disease Drugs Import Volume

Anemia Import Volume and Market Share

Anemia Treatment Drugs Import Volume by Drugs Classification

Mecobalamin Import Volume and Market Share

Cobamamide Import Volume and Market Share

Ferrous Succinate Import Volume and Market Share

Leucogen Import Volume and Market Share

Galanthamine Import Volume and Market Share

Neutropenia and Agranulocytosis Treatment Drugs Import Volume and Market Share

Neutropenia and Agranulocytosis Treatment Drugs Import Volume by Drugs Classification

VitamineB4 Import Volume and Market Share

Batilol Import Volume and Market Share

Inosine Import Volume and Market Share

Deoxyribonucleotide Import Volume and Market Share

Adrenocortical Hormone Import Volume and Market Share

Granulocyte Colony-Stimulating Factor(G-CSF) Import Volume and Market Share

Leukemia Treatment Drugs Import Volume and Market Share

Leukemia Treatment Drugs Import Volume by Drugs Classification

Interferon Treatment Drugs Import Volume and Market Share

Imatinib Mesylate Treatment Drugs Import Volume and Market Share

Rituximab Treatment Drugs Import Volume and Market Share

Pirarubicin Treatment Drugs Import Volume and Market Share

Hydroxycampothecin Treatment Drugs Import Volume and Market Share

Other Blood Disease Drugs Import Volume and Market Share



VI. MARKETING STRATEGIES



China’s Distribution Channel



PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT